Skip to main content

Table 1 Clinical features of the investigational group (vitreomacular traction - VMT) and controls throughout follow-up

From: Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction

 

Idiopathic VMT

Control

p

Age (years)

59.2 ± 3.4

59.6 ± 1.4

0.998

Sex (f: m)

9:7

8:8

0.999

Axial length (mm)

23.92 ± 0.78

23.85 ± 0.05

0.899

BCVA (logMAR) baseline

0.23 ± 0.04

0.00

< 0.001

BCVA 1 month

0.12 ± 0.03

0.00

< 0.001

CFT baseline

430 ± 98

215 ± 8

< 0.001

CFT 1 month

272 ± 31

216 ± 7

< 0.001

  1. f female, m male, BCVA best corrected visual acuity, CFT central foveal thickness, logMAR logarithm of the minimal angle of resolution